Biogen Idec Inc Takes Over #163 Spot From Baxter International Inc.
Posted on December 27, 2012 at 11:46 AM EST
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Biogen Idec Inc (BIIB) has taken over the #163 spot from Baxter International Inc. (BAX), according to ETF Channel.